Onconetix, Inc.
ONCO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001782107
No open-market purchases or sales by Onconetix, Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $73.9K in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Onconetix, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +3 vs. Q1 2024
- Shares held
- 2.95M
- +558.8K (+23.4%) vs. Q1 2024
- Total value
- $491.6K
- +$123.9K (+33.7%) vs. Q1 2024
- New holders
- 7
- 3 more added
- Sold out
- 4
- 0 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ONCO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 6 | $73.9K |
| Q1 2026 | 5 | $24.9K |
| Q4 2025 | 7 | $95.3K |
| Q3 2025 | 8 | $303.7K |
| Q2 2025 | 7 | $43.0K |
| Q1 2025 | 13 | $26.7K |
| Q4 2024 | 11 | $241.7K |
| Q3 2024 | 8 | $3.23M |
| Q2 2024 | 20 | $491.6K |
| Q1 2024 | 17 | $367.8K |
| Q4 2023 | 22 | $478.6K |
| Q3 2023 | 19 | $1.82M |
| Q2 2023 | 20 | $2.70M |
| Q1 2023 | 13 | $1.73M |
| Q4 2022 | 18 | $2.13M |
| Q3 2022 | 19 | $4.03M |
| Q2 2022 | 10 | $2.37M |
| Q1 2022 | 13 | $25.9M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Onconetix, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| American Financial Group Inc | 1,440,927 | $241.0K | 0.10% | 00.0% | Unchanged |
| Cetera Investment Advisers | 320,000 | $53.5K | 0.00% | 00.0% | Unchanged |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 306,079 | $51.2K | 0.00% | +306,079 | New |
| Bank of America Corp | 125,134 | $20.9K | 0.00% | +134+0.1% | Added |
| Susquehanna International Group, LLP | 113,681 | $19.0K | 0.00% | +113,681 | New |
| HRT Financial LP | 104,594 | $17.0K | 0.00% | +104,594 | New |
| Fifth Third Bancorp | 96,196 | $16.1K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 95,262 | $15.9K | 0.00% | +42,148+79.4% | Added |
| Jane Street Group, LLC | 87,026 | $14.6K | 0.00% | +87,026 | New |
| Vanguard Group Inc | 73,513 | $12.3K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 53,561 | $8.96K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 38,293 | $6.40K | 0.00% | 00.0% | Unchanged |
| Bahl & Gaynor Inc | 34,710 | $5.80K | 0.00% | 00.0% | Unchanged |
| Baader Bank INC | 27,500 | $3.75K | 0.00% | +27,500 | New |
| XTX Topco Ltd | 17,735 | $2.96K | 0.00% | +17,735 | New |
| Tower Research Capital LLC (TRC) | 12,777 | $2.13K | 0.00% | +4,417+52.8% | Added |
| Aspire Private Capital, LLC | 600 | $100 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 400 | $67 | 0.00% | +400 | New |
| Bogart Wealth, LLC | 13 | $2 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 140 | $0 | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −113,434−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −27,721−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,599−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −128−100.0% | Sold out |